skip navigation links
National Cancer Institute National Cancer Institute U.S. National Institutes of Health
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 14.12e (Release date: 2014-12-29-08:00)
SearchBox Top
SearchBox Bottom
Recombinant MAGE-3.1 Antigen (Code C38724)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant MAGE-3.1 Antigen

Definition: A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. (NCI04)

Display Name: Recombinant MAGE-3.1 Antigen

Label: Recombinant MAGE-3.1 Antigen

NCI Thesaurus Code: C38724 (Search for linked caDSR metadata)

Synonyms & Abbreviations: (see Synonym Details)
Recombinant MAGE-3.1 Antigen

External Source Codes: 
PDQ Closed Trial Search ID 42271 (check for NCI PDQ closed clinical trial info)
PDQ Open Trial Search ID 42271 (check for NCI PDQ open clinical trial info)
UMLS CUI C1510427

Other Properties:
code C38724
Contributing_Source CTRP
Legacy_Concept_Name Recombinant_MAGE-3-1_Antigen
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Immunologic Factor

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom